 - Patients receiving a bisphosphonate must be on a stable dose and must have started the bisphosphonate 4 weeks prior to initiating protocol treatment. Patients do not have to be on a bisphosphonate to qualify for the study; patients may initiate bisphosphonate therapy after completion of Cycle 1, if clinically indicated 